Premium
Neurology (49)
Author(s) -
Khattab Jihad,
Terebelo Howard R.,
Dabas Basel
Publication year - 2001
Publication title -
pain practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 58
eISSN - 1533-2500
pISSN - 1530-7085
DOI - 10.1111/j.1533-2500.2001.1011-49.x
Subject(s) - medicine , paclitaxel , neurotoxicity , amputation , phantom limb pain , tendon , surgery , chemotherapy , toxicity
Phantom limb pain as a manifestation of paclitaxel neurotoxicity. (Providence Hospital, Southfield, MI) Mayo Clin Proc 2000;75:740–742. This case report described 2 patients with prior amputation who experienced phantom limb pain (PLP) after receiving paclitaxel therapy. A third patient experienced disabling neurotoxicity in the extremity of a prior ulnar nerve and tendon transposition after receiving paclitaxel. This unique syndrome should be identified as a direct causal effect of paclitaxel. The pathophysiology of PLP and the treatment options are reviewed. Conclude that physicians should be aware that PLP can occur after initiation of paclitaxel.